Procter & Gamble Company (The) $PG Shares Sold by Lmcg Investments LLC

Key Points

• Lmcg Investments reduced its Procter & Gamble stake by 22.6% in the third quarter, selling 16,756 shares and retaining 57,471 shares valued at approximately $8.35 million. Institutional investors and hedge funds collectively own 65.77% of PG.
• Procter & Gamble offers a quarterly dividend of $1.0885, or $4.35 annually, yielding about 2.8%; the company recently recorded its 70th consecutive annual dividend increase.
• Analysts maintain a generally favorable view, with a “Moderate Buy” consensus and an average price target of $162.20, but concerns remain over modest 1%–3% organic sales growth, pricing pressure, and potential post-earnings weakness.

Lmcg Investments LLC lowered its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 22.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 57,471 shares of the company's stock after selling 16,756 shares during the quarter. Lmcg Investments LLC's holdings in Procter & Gamble were worth $8,349,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of PG. BlackRock Inc. acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $27,862,105,000. State Street Corp grew its holdings in shares of Procter & Gamble by 1.0% in the second quarter. State Street Corp now owns 102,216,308 shares of the company's stock valued at $14,988,999,000 after purchasing an additional 965,461 shares in the last quarter. Bank of America Corp DE acquired a new position in shares of Procter & Gamble in the second quarter worth $3,850,628,000. Bank of New York Mellon Corp acquired a new stake in shares of Procter & Gamble in the second quarter valued at $2,281,505,000. Finally, Dimensional Fund Advisors LP boosted its holdings in Procter & Gamble by 2.6% in the first quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company's stock valued at $1,704,182,000 after purchasing an additional 300,280 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble’s dividend remains a key support for the stock. The company recently recorded its 70th consecutive annual dividend increase, reinforcing its appeal to income-focused investors, particularly while interest rates remain elevated. The Ultimate Dividend Growth Stock to Buy With $100 Right Now
• Positive Sentiment: Royal Bank of Canada reaffirmed its “outperform” rating and maintained a $166 price target, implying additional upside from the referenced trading level. Benzinga analyst-rating report
• Neutral Sentiment: Investors are comparing PG’s dependable profitability and cash flow from essential household products with higher-risk consumer brands such as Nike. This supports PG’s defensive profile but does not provide a new earnings catalyst. Nike vs. Procter & Gamble
• Negative Sentiment: Procter & Gamble expects only 1% to 3% organic sales growth, raising concerns that the company’s large brands may be struggling to generate stronger underlying demand. Procter & Gamble Expects 1% to 3% Organic Growth
• Negative Sentiment: The earnings preview identifies a central risk: recovering product volumes could be offset by pricing headwinds, potentially limiting revenue growth and margins. Procter & Gamble Earnings Preview
• Negative Sentiment: Options-market activity indicates traders are positioned for PG shares to decline following the earnings release, reflecting elevated near-term uncertainty. Barchart Earnings Analysis

Procter & Gamble Stock Down 1.5%

Shares of NYSE PG opened at $156.97 on Thursday. The business has a 50-day moving average of $147.65 and a two-hundred day moving average of $146.83. The company has a market capitalization of $364.58 billion, a price-to-earnings ratio of 23.71, a price-to-earnings-growth ratio of 3.96 and a beta of 0.39. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.68 and a quick ratio of 0.47.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating analysts' consensus estimates of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. The business had revenue of $21.20 billion for the quarter, compared to the consensus estimate of $21.38 billion. During the same quarter in the prior year, the business posted $1.48 EPS. The business's revenue for the quarter was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, analysts forecast that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble's dividend payout ratio (DPR) is 65.71%.

Analysts Set New Price Targets

PG has been the subject of several analyst reports. Evercore raised Procter & Gamble from an "in-line" rating to an "outperform" rating and set a $166.00 target price for the company in a research note on Tuesday, October 6th. JPMorgan Chase & Co. reduced their price target on Procter & Gamble from $164.00 to $162.00 and set an "overweight" rating on the stock in a research report on Thursday, July 16th. Bank of America decreased their price objective on Procter & Gamble from $170.00 to $166.00 and set a "buy" rating for the company in a research note on Friday, July 10th. UBS Group reissued a "buy" rating on shares of Procter & Gamble in a research report on Friday, October 16th. Finally, Barclays upped their target price on shares of Procter & Gamble from $146.00 to $152.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 21st. Fourteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $162.20.

Insider Activity

In other Procter & Gamble news, insider Susan Whaley sold 2,369 shares of Procter & Gamble stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $344,310.46. Following the transaction, the insider owned 30,730 shares of the company's stock, valued at $4,466,298.20. The trade was a 7.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Matthew Janzaruk sold 359 shares of the stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the sale, the chief accounting officer directly owned 1,271 shares of the company's stock, valued at $184,600.04. The trade was a 22.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,135 shares of company stock worth $2,189,970 over the last ninety days. 0.23% of the stock is owned by corporate insiders.

Procter & Gamble Profile

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.